Know Cancer

or
forgot password

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects


N/A
N/A
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects


Inclusion Criteria:



- Post-menopausal woman without superior age limit

- No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone
receptor positive, treated by conservative surgery or total mastectomy and requiring
additive treatment by radiotherapy and hormonotherapy

- The patients including in another clinical trial can be include in this observatory

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

radiation side effects

Outcome Description:

Describe, in real situation, the ionisant radiation effects on the healthy tissues in patients receiving anastrazole in association or sequential with radiotherapy

Outcome Time Frame:

5 years after the end of radiotherapy

Safety Issue:

Yes

Principal Investigator

Yazid BELKACEMI, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre Oscar Lambret

Authority:

France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé

Study ID:

ORACLES

NCT ID:

NCT01183832

Start Date:

August 2005

Completion Date:

August 2014

Related Keywords:

  • Breast Cancer
  • Breast cancer
  • radiotherapy
  • hormonotherapy
  • Breast Neoplasms

Name

Location